What this means
This is a plan for a study that has not started yet. It will test whether a 12-week smart care program helps frailty, daily activity, and readmissions.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 65 and over · 156 hospitalized older adults with kidney disease
- Where
- 1 site
The science
- Registered title
- The Effects of Intelligent Intervention Programs on Hospitalized Elderly People With Frailty.
- Trial ID
- NCT06875024 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Frailty in Older Adults
- What is tested
- Intelligent intervention programs
- Sponsor
- National Taipei University of Nursing and Health Sciences
- Ages
- 65 Years to no maximum
- Dates
- First posted Mar 13, 2025 · updated Apr 3, 2025
Registry summary
Background: As the aging population grows, hospitalized elderly individuals with frailty have become a major concern. Frailty is a complex syndrome linked to aging, marked by dependency and vulnerability. Elderly patients often face chronic diseases, making them more susceptible to frailty. Studies show frailty prevalence in hospitalized elderly patients is 88.7%, and 75.3% among kidney disease patients. Frailty is associated with advanced age, female gender, low body mass index, comorbidities, and poor nutrition, increasing the risks of falls, hospitalization, and mortality. Frail kidney disease patients face worse outcomes. However, frailty is reversible with early intervention. Current treatments, based on comprehensive geriatric assessment (CGA), require significant resources. This study aims to explore frailty prevention and care through research and intervention development.
Purpose: To explore the effectiveness of an intelligent intervention program in improving frailty among hospitalized elderly individuals.
Methods: An experimental research design was adopted. A total of 156 hospitalized elderly patients with kidney disease who met the inclusion criteria were recruited through convenience sampling. Participants were randomly assigned to either the experimental group (n = 78) or the control group (n = 78). The experimental group received a 12-week intelligent intervention program, while the control group received routine care.Subsequently, data on frailty level, daily living function 30 days after discharge, and unexpected readmission rate 30 days after discharge will be collected by researchers and analyzed using SPSS 22.0, including chi-square tests, repeated measures ANOVA, and Generalized Estimating Equations (GEE) for intra-group and inter-group comparisons of each outcome variable.
Expected research results: This study aims to understand the current status and influencing factors of frailty among hospitalized elderly patients with kidney disease and to develop an intelligent intervention program. The goal is to provide clinical nursing staff with a frailty care strategy for hospitalized patients, effectively reducing frailty among elderly inpatients, improving their daily functional ability after discharge, and decreasing hospital readmission rates.
Condition or disease: frailty Intervention/treatment: intelligent intervention program
Sites (1)
- National Taipei University of Nursing and Health Sciences, Taipei,, Taipei, Taiwan